Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7433806
Reference Type
Journal Article
Title
Conjunctival and Corneal Tumors: Ocular Surface Squamous Neoplasia
Author(s)
Pe’er, J; Frenkel, S; Singh, AD; ,
Year
2019
Publisher
Springer International Publishing
Location
Cham
Book Title
Clinical Ophthalmic Oncology
Page Numbers
159-184
DOI
10.1007/978-3-030-06046-6_15
URL
http://link.springer.com/10.1007/978-3-030-06046-6_15
Exit
Abstract
Ocular surface squamous neoplasia (OSSN) is a term used for precancerous and cancerous epithelial lesions of the conjunctiva and cornea. It is more common in countries with high exposure to solar ultraviolet radiation. The two other major etiological factors in the development of OSSN are human papillomavirus and AIDS. The OSSN lesions arise commonly within the interpalpebral fissure, mostly at the limbus. It may be difficult to differentiate clinically between conjunctival intraepithelial neoplasia (CIN) and invasive squamous cell carcinoma. Despite modern imaging techniques, the definite diagnosis is made by incisional or excisional biopsy. Surgical excision of OSSN is the traditional method of treatment. Adjuvant cryotherapy and brachytherapy have been used to reduce the recurrence rate. Since the 1990s, topical medical therapy has been used extensively as the sole treatment or as an adjuvant to surgical excision. Topical drops of mitomycin C, 5-fluorouracil, and interferon-α2b, have shown promising results, lowering the recurrence rate significantly. Intraocular invasion and metastasis of conjunctival squamous cell carcinoma are extremely rare.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity